Article info

Original research
Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites

Authors

  • Jordan W Conway Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, AustraliaCharles Perkins Centre, The University of Sydney, Sydney, New south Wales, Australia PubMed articlesGoogle scholar articles
  • Robert V Rawson Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, AustraliaDepartment of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Serigne Lo Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Tasnia Ahmed Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Ismael A Vergara Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, AustraliaCharles Perkins Centre, The University of Sydney, Sydney, New south Wales, Australia PubMed articlesGoogle scholar articles
  • Tuba N Gide Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, AustraliaCharles Perkins Centre, The University of Sydney, Sydney, New south Wales, Australia PubMed articlesGoogle scholar articles
  • Grace Heloise Attrill Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, AustraliaCharles Perkins Centre, The University of Sydney, Sydney, New south Wales, Australia PubMed articlesGoogle scholar articles
  • Matteo S Carlino Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, AustraliaWestmead and Blacktown Hospitals, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Robyn P M Saw Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, AustraliaDepartment of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, AustraliaMater Hospital, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • John F Thompson Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, AustraliaDepartment of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, AustraliaMater Hospital, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Andrew J Spillane Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, AustraliaRoyal North Shore Hospital, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Kerwin F Shannon Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, AustraliaDepartment of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, AustraliaChris O'Brien Lifehouse, Camperdown, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Brindha Shivalingam Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, AustraliaChris O'Brien Lifehouse, Camperdown, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Alexander Maxwell Menzies Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, AustraliaMater Hospital, Sydney, New South Wales, AustraliaRoyal North Shore Hospital, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • James S Wilmott Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, AustraliaCharles Perkins Centre, The University of Sydney, Sydney, New south Wales, Australia PubMed articlesGoogle scholar articles
  • Georgina V Long Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, AustraliaCharles Perkins Centre, The University of Sydney, Sydney, New south Wales, AustraliaMater Hospital, Sydney, New South Wales, AustraliaRoyal North Shore Hospital, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Richard A Scolyer Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, AustraliaCharles Perkins Centre, The University of Sydney, Sydney, New south Wales, AustraliaDepartment of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Ines Pires da Silva Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, AustraliaCharles Perkins Centre, The University of Sydney, Sydney, New south Wales, AustraliaWestmead and Blacktown Hospitals, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ines Pires da Silva; Ines.Silva{at}melanoma.org.au
View Full Text

Citation

Conway JW, Rawson RV, Lo S, et al
Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites

Publication history

  • Accepted August 24, 2022
  • First published September 12, 2022.
Online issue publication 
September 12, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.